🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT)

RecruitingNAAges 29 Years - 39 YearsFemaleSunkaky Medical Cooperation
NCT07066267 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to investigate the potential of autologous adipose stem cell (ASC) mitochondrial transfer (ASCENT) to oocytes along with intracytoplasmic sperm injection (ICSI)as a means of enhancing embryo development and improving the success rate of in patients with a history of multiple IVF failures. Embryo quality plays a crucial role in determining the success of assisted reproductive technologies and directly contributes to repeated pregnancy failures. Several factors, including age, physiological conditions, genetics, and environmental influences, can significantly impact embryo quality. Oocytes, the largest cells in the human body, are heavily reliant on mitochondria. Mitochondria's role in providing energy for oocytes is crucial, and insufficient energy production has been linked to poor oocyte and embryo quality. Some human studies have shown that increasing oocyt

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Having at least three previous failed IVF trial * Specifically consented for to collect biopsies for Preimplantation generic testing for aneuploidy (PGTA) analysis * Specifically consented for to have single blastocyst transfer (recommended) * No major uterine or ovarian abnormalities * Specifically consented for to have all embryos frozen * Specifically consented for to collect adipose tissues from subcutaneous liposuction * BMI level level \<26kg/m2 Exclusion Criteria: * Ovarian endometriosis with Chocolate cysts (American Fertility Society (AFS)) classification type 3 and 4 * Any medical contraindication oocyte retrieval or subsequent procedures Ovarian hyperstimulation syndrome Bleeding disorders Sex hormone allergies Severe emotional defect on injections * Severe sperm abnormalities * \<5 million/mL motile sperm * Uterine structural anomalies * Polycystic ovaries * Premature ovarian failure
💊

What it tests

  • Experimental
📍

Where

1 site
Wish Fertility Hospital Pvt. Ltd
Colombo, Sri Lanka
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy